Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now early-phase tilt small index

Nitric Oxide: early-phase trial registry

3 of 4 indexed Nitric Oxide trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Nitric Oxide: 4 US clinical trials tracked, 3 recruiting.

Nitric Oxide is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Xijing Hospital, running 1 of these trials.

Enrollment posture brief

Registry condition nitric-oxide

OPEN 3 | RECR 75% | LATE 1 | EARLY 2 | RANK #4115 | SPON 1

Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)

Ablation80%ACL Reconstruction80%Nitric Oxide (this)75%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Nitric Oxide

Nitric Oxide lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nitric Oxide on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nitric Oxide is recruiting above its size-band peers.

    3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 22Phase 31

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1

Named interventions

Most-linked intervention names on Nitric Oxide records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

L-NMMA and Sodium Nitrite Drug
1 trials
Standard Care Arm Drug
1 trials
Nitric Oxide Gas Drug
1 trials
200 mg CITRAPEAK® (glucosyl-hesperidin) supplementation Dietary supplement
1 trials
400 mg CITRAPEAK® (glucosyl-hesperidin) supplementation Dietary supplement
1 trials
Placebo + supervised exercise therapy Combination
1 trials
Nitrate-Rich Beetroot Juice + supervised exercise therapy Combination
1 trials
Supervised Treadmill Exercise Behavioral
1 trials

US sites by state

Facility locations filed on Nitric Oxide trials. A trial with sites in several states counts in each.

Missouri 1 trials
Maryland 1 trials
Massachusetts 1 trials
Illinois 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Nitric Oxide page

4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nitric Oxide condition card totals 4 registered trials; most-linked intervention L-NMMA and Sodium Nitrite; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.